Editor’s Pick: Protecting the Heart in Cancer Patients: The Role of Cardio-Oncology

  • Home / Editor’s Pick: Protecting the Heart in Cancer Patients: The Role of Cardio-Oncology

Editor’s Pick: Protecting the Heart in Cancer Patients: The Role of Cardio-Oncology

Our Editor’s pick for this issue is a thought-provoking paper from Ronald J. Krone, discussing the role cardio-oncology has in protecting the heart in cancer patients. Collaboration between oncologists and cardio-oncologists is imperative in developing cardiologists with expertise in understanding the impact that various cancer regimens have on the heart and to develop programmes to manage or prevent heart damage, ultimately ensuring better quality of life in the cancer patient. Samantha Warne

*Ronald J. Krone

Washington University School of Medicine, St. Louis, Missouri, USA
*Correspondence to rkrone@wustl.edu

Disclosure: The author has declared no conflicts of interest.
Received: 30.01.17 Accepted: 04.09.17
Citation: EMJ Cardiol. 2017;5[1]:47-52.

Abstract

Cardiac disease often impacts cancer therapy, from direct toxicity of cancer therapeutic agents to the coronary endothelium, the myocardium, heart valves, and other structures. This has spawned the development of cardio-oncology programmes, emphasising collaboration between oncologists and cardio-oncologists in order to develop cardiologists with expertise in understanding the impact of various cancer regimens on the heart and developing programmes to manage or prevent heart damage. Cardiac disease and cancer both become more common as people age, as such cardiac disease, including coronary disease, should be screened for and risk factors treated when possible. Cancer-caused cardiac damage is much more responsive to therapy if treated early, so protocols for monitoring heart function to identify early injury need to be established and followed. Newer measures of ventricular function can identify heart injury before a reduction in ejection fraction to permit early initiation of therapy, and protocols to utilise these measures need to be incorporated into routine surveillance. Research is underway to evaluate regimens for cardiac protection prior to the cancer therapy, but at present, the data do not permit broad recommendations.

This article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.

The post Editor’s Pick: Protecting the Heart in Cancer Patients: The Role of Cardio-Oncology appeared first on European Medical Journal.

About Post Author

Medical CPD & News

The Digitalis CPD trawler searches the web for all the latest news and journals.

Privacy Preference Center

Close your account?

Your account will be closed and all data will be permanently deleted and cannot be recovered. Are you sure?

Are you sure?

By disagreeing you will no longer have access to our site and will be logged out.